Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2022-04-01
Cyfres:CJC Open
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg